MedTrace Logo

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

NCT05195515 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-03-03

No results posted yet for this study

Summary

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

Conditions

Sponsors & Collaborators

  • University of Aarhus

    collaborator OTHER

  • National Research Center for Survivorship and Late Adverse Effects Following Pelvic Organ Cancer, Denmark

    collaborator UNKNOWN

  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Jørgen Bjerggaard Jensen, Professor · Department of Urology, Aarhus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195515 on ClinicalTrials.gov